Kerr Expands Tissue Management Line with Hemostasyl

ORANGE, CA – October 31, 2009 – Kerr introduces the latest innovation in tissue management, Hemostasyl^™—a highly efficient hemostatic agent that stops bleeding with precision and ease. When moderate bleeding occurs and gingival retraction is not required, Hemostasyl is an ideal choice. This product is exceptionally easy to place, and less material is required compared to other similar hemostatic agents on the market.

Product Manager James Lobsenz said, “With Hemostasyl, doctors now have a material that is incredibly easy to dispense using a convenient syringe delivery and a viscosity that stays in place and controls blood and other fluids well.”

Hemostasyl is brightly colored, so it is easy to see and clean up, and its composition helps adhere to soft and hard tissue with ease, making placement a breeze. With a concentration of 15% aluminum chloride, this material is an effective way to stop bleeding in many clinical applications such as Class V composite placement, cementation, and scaling in perio cases. Compromising esthetics of the procedure is not a worry—Hemostasyl contains no ferric sulfate, unlike similar products on the market, which can stain proteins a black color, including soft tissue and dentin.

For gingival retraction needs, the Kerr Tissue Management line also offers Expasyl™, an atraumatic gingival retraction paste, now in a pleasant new strawberry taste.

To learn more about Hemostasyl or our broad portfolio of products, visit kerrdental.com/hemostasyl or call 800.KERR.123. To find out more about continuing education online and free CE credit, visit Kerr University at kerrdental.com/education for upcoming live webcasts, on-demand video, and the latest CE articles.